OR WAIT null SECS
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Lexington, KY-One of the newest viscoelastic products approved by the FDA is 1.2% sodium hyaluronate (CoEase, Advanced Medical Optics), which exemplifies the trend toward developing agents with both dispersive and cohesive properties.
Related Content: